Artiva Biotherapeutics (ARTV) Interest & Investment Income (2023 - 2026)
Artiva Biotherapeutics' (ARTV) quarterly Interest & Investment Income came in at $912000.0 in Q1 2026, down 51.07% year-on-year from $1.9 million in Q1 2025, and down 21.51% on a QoQ basis from $1.2 million in Q4 2025.
Artiva Biotherapeutics (ARTV) Interest & Investment Income (2023 - 2026) Analysis & Trends
Artiva Biotherapeutics (ARTV) has 4 years of Interest & Investment Income data on file, last reported at $912000.0 in Q1 2026.
- On a quarterly basis, Interest & Investment Income fell 51.07% year-over-year to $912000.0 in Q1 2026; TTM through Mar 2026 was $5.0 million, a 23.71% decrease from a year earlier, with the FY2025 full-year figure at $6.0 million, up 11.4% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $912000.0, down from $1.2 million in the prior quarter.
- Over the last five years, Interest & Investment Income for ARTV reached as high as $2.2 million in Q4 2024 and fell as low as $418000.0 in Q3 2023.
- Historically, Interest & Investment Income has averaged $1.1 million across 4 years, with a median of $1.0 million in 2025.
- Across the five-year window, Interest & Investment Income jumped 341.63% in 2024 and slumped 51.07% in 2026, its largest moves.
- Year by year, Interest & Investment Income stood at $583000.0 in 2023, then soared by 273.41% to $2.2 million in 2024, then sank by 46.62% to $1.2 million in 2025, then decreased by 21.51% to $912000.0 in 2026.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $912000.0 in Q1 2026, $1.2 million in Q4 2025, and $1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Artiva Biotherapeutics | 256.04 Mn | 256.04 Mn | - | 912,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 912,000.00 |
| Dec 31, 2025 | 1.16 Mn |
| Sep 30, 2025 | 1.37 Mn |
| Jun 30, 2025 | 1.56 Mn |
| Mar 31, 2025 | 1.86 Mn |
| Dec 31, 2024 | 2.18 Mn |
| Sep 30, 2024 | 1.85 Mn |
| Jun 30, 2024 | 676,000.00 |
| Mar 31, 2024 | 650,000.00 |
| Dec 31, 2023 | 583,000.00 |
| Sep 30, 2023 | 418,000.00 |
| Jun 30, 2023 | 509,000.00 |